相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery
Huijuan Song et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug
Dongping Zhao et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
Sophie Marchal et al.
DRUGS (2015)
Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice
Dai Hai Nguyen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate
Ying Tu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery
Minghui Xu et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2015)
Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses
Manoj K. Sabnani et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Preclinical Evaluation of Antitumor Activity of Acid-Sensitive PEGylated Doxorubicin
Diankui Sun et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin
Lipeng Qiu et al.
BIOMATERIALS (2014)
Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR
Jie Shen et al.
BIOMATERIALS (2014)
Cisplatin-loaded polymer/magnetite composite nanoparticles as multifunctional therapeutic nanomedicine
Yan Zhang et al.
CHINESE JOURNAL OF POLYMER SCIENCE (2014)
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery
Gozde Unsoy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
Charlene M. Dawidczyk et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Doxorubicin Nanoconjugates
Kannan Deepa et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2014)
MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: Implication for intestinal barrier function
Kenji Ikemura et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Nanotechnology and drug resistance Preface
Tamara Minko
ADVANCED DRUG DELIVERY REVIEWS (2013)
Multidrug resistance: Physiological principles and nanomedical solutions
Sijumon Kunjachan et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Qi Yin et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition
Un-Jung Yun et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
Wei-Wu Chen et al.
BREAST (2013)
Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
Man Yu et al.
CANCER AND METASTASIS REVIEWS (2013)
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts
Preethy Prasad et al.
CANCER LETTERS (2013)
Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles
Qiu Zhang et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
Chung Ping Leon Wan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies
Hongfang Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Reversal of Multidrug Resistance by Mitochondrial Targeted Self-Assembled Nanocarrier Based on Stearylamine
Zhiwen Zhang et al.
MOLECULAR PHARMACEUTICS (2013)
Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
Ping Ma et al.
NANO TODAY (2013)
Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells
Fei Li et al.
POLYMER INTERNATIONAL (2013)
The role of endosome evasion bypass in the reversal of multidrug resistance by lipid/nanoparticle assemblies
Zhen Li et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Self-assembling doxorubicin prodrug forming nanoparticles for cancer chemotherapy: synthesis and anticancer study in vitro and in vivo
Pengfei Gou et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells
Xinxin Zhang et al.
BIOMATERIALS (2012)
Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance
Xiufeng Ji et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance
Elmira Bajelan et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2012)
Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin
Xiao-Bing Xiong et al.
ACS NANO (2011)
Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
Huan Meng et al.
ACS NANO (2011)
Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells
Yu-Cai Wang et al.
BIOCONJUGATE CHEMISTRY (2011)
The Role of Estrogen and Estrogen Receptors in Chemoresistance
M. Sui et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Forrest M. Kievit et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Nuclear drug delivery for cancer chemotherapy
Meihua Sui et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism
Jianan Shen et al.
NANOSCALE (2011)
Poly(L-lactide)-Vitamin E TPGS Nanoparticles Enhanced the Cytotoxicity of Doxorubicin in Drug-Resistant MCF-7 Breast Cancer Cells
Po-Yu Li et al.
BIOMACROMOLECULES (2010)
Endocytosis of nanomedicines
Gaurav Sahay et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery
Youqing Shen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects
Huadong Tang et al.
NANOMEDICINE (2010)
Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
Michiro Susa et al.
PLOS ONE (2010)
Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates
Blanka Rihova
ADVANCED DRUG DELIVERY REVIEWS (2009)
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Paul D. W. Eckford et al.
CHEMICAL REVIEWS (2009)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver
Nina Kassner et al.
DRUG METABOLISM AND DISPOSITION (2008)
Polymer architecture and drug delivery
LY Qiu et al.
PHARMACEUTICAL RESEARCH (2006)
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response
R Rajan et al.
CANCER (2004)